Cardiovascular Department, Stony Brook Medicine, Stony Brook, New York, USA.
Internal Medicine Department, Lenox Hill Hospital, New York, New York, USA.
Respiration. 2022;101(3):334-344. doi: 10.1159/000519406. Epub 2021 Dec 6.
This meta-analysis assessed the effect of long-term (>6 weeks) noninvasive positive airway pressure (PAP) on diastolic function in patients with obstructive sleep apnea (OSA).
We searched the databases for randomized clinical trials including Ovid MEDLINE, Ovid Embase Scopus, Web of Science, Google Scholar, and EBSCO CINAHL from inception up to December 20, 2019. The search was not restricted to time, publication status, or language. Two independent investigators screened the studies and extracted the data, in duplicate. Risk of bias was assessed using Cochrane collaboration tools.
A total of 2,753 abstracts were resulted from literature search. A total of 9 randomized clinical trials assessing the effect of long-term (>6 weeks) PAP on diastolic function in patients with OSA including 833 participants were included. The following echo parameters were found in treated patients: a decrease in deceleration time (-39.49 ms CI [-57.24, -21.74]; p = 0.000), isovolumic relaxation time (-9.32 ms CI [-17.08, -1.57]; p = 0.02), and the ratio of early mitral inflow velocity to mitral annular early diastolic velocity (-1.38 CI [-2.6, -0.16]; p = 0.03). However, changes in left-atrial volume index and the ratio of early to late mitral inflow velocities were not statistically different. The risk of bias was mild to moderate among the studies.
Our results suggest that chronic treatment of moderate to severe OSA with noninvasive PAP is associated with improvement in echocardiographic findings of diastolic dysfunction.
本荟萃分析评估了长期(>6 周)无创性气道正压通气(PAP)对阻塞性睡眠呼吸暂停(OSA)患者舒张功能的影响。
我们检索了从 Ovid MEDLINE、Ovid Embase Scopus、Web of Science、Google Scholar 和 EBSCO CINAHL 数据库中收录的随机临床试验,检索时间截至 2019 年 12 月 20 日。检索未对时间、发表状态或语言进行限制。两名独立的研究者对研究进行筛选并提取数据,重复进行两次。使用 Cochrane 协作工具评估偏倚风险。
从文献检索中得到了 2753 篇摘要。共有 9 项随机临床试验评估了长期(>6 周)PAP 对 OSA 患者舒张功能的影响,共纳入 833 名参与者。在接受治疗的患者中发现以下超声心动图参数的变化:减速时间缩短(-39.49ms CI [-57.24, -21.74];p = 0.000)、等容舒张时间缩短(-9.32ms CI [-17.08, -1.57];p = 0.02)和二尖瓣早期流入速度与二尖瓣环早期舒张速度的比值降低(-1.38 CI [-2.6, -0.16];p = 0.03)。然而,左心房容积指数和二尖瓣早期与晚期流入速度的比值变化无统计学差异。研究的偏倚风险为轻度至中度。
我们的结果表明,用无创性 PAP 慢性治疗中重度 OSA 与改善舒张功能障碍的超声心动图发现有关。